BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22942707)

  • 41. Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients.
    Yamada H; Shinmura K; Goto M; Iwaizumi M; Konno H; Kataoka H; Yamada M; Ozawa T; Tsuneyoshi T; Tanioka F; Sugimura H
    Mol Cancer; 2009 Aug; 8():63. PubMed ID: 19671196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Promoter methylation of H-cadherin is a potential biomarker in patients with bladder transitional cell carcinoma.
    Lin YL; Liu XQ; Li WP; Sun G; Zhang CT
    Int Urol Nephrol; 2012 Feb; 44(1):111-7. PubMed ID: 21516472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of CDH13 promoter methylation in the carcinogenesis, progression, and prognosis of colorectal cancer: A systematic meta-analysis under PRISMA guidelines.
    Ye M; Huang T; Li J; Zhou C; Yang P; Ni C; Chen S
    Medicine (Baltimore); 2017 Jan; 96(4):e5956. PubMed ID: 28121942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between Methylation of FHIT and CDH13 Gene Promoter Region and Liver Cancer.
    Tuoya AD; Wang DX; Xing YS; Liu RJ; Hu YX; Zhang MD; Bai TY; Lv XL; Li J; Chang FH
    Curr Med Sci; 2020 Jun; 40(3):502-509. PubMed ID: 32474857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
    Bustos-Carpinteyro AR; Oliveira C; Sousa A; Oliveira P; Pinheiro H; Carvalho J; Magaña-Torres MT; Flores-Miramontes MG; Aguilar-Lemarroy A; Jave-Suárez LF; Peregrina-Sandoval J; Cruz-Ramos JA; Sánchez-López JY
    BMC Cancer; 2019 Jan; 19(1):69. PubMed ID: 30642281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of expression level and methylation profile of
    Mohammadi Z; Azad M; Foroughi F; Khojastehpour S; Gheibi N; Samiee-Rad F; Maali A; Ahmadi MH
    J Cancer Res Ther; 2021; 17(6):1328-1334. PubMed ID: 34916361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methylation status of CDH1 gene in samples of gastric mucous from Brazilian patients with chronic gastritis infected by Helicobacter pylori.
    Kague E; Thomazini CM; Pardini MI; Carvalho Fd; Leite CV; Pinheiro NA
    Arq Gastroenterol; 2010; 47(1):7-12. PubMed ID: 20520968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinico-epigenetic combination including quantitative methylation value of DKK3 augments survival prediction of the patient with cervical cancer.
    Kang WS; Cho SB; Park JS; Lee MY; Myung SC; Kim WY; Lee SH; Kim DH; Lee EJ
    J Cancer Res Clin Oncol; 2013 Jan; 139(1):97-106. PubMed ID: 22961207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chromosome 16q genes
    Alkebsi L; Handa H; Yokohama A; Saitoh T; Tsukamoto N; Murakami H
    Oncol Lett; 2016 Nov; 12(5):3523-3530. PubMed ID: 27900031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.
    Corso G; Carvalho J; Marrelli D; Vindigni C; Carvalho B; Seruca R; Roviello F; Oliveira C
    J Clin Oncol; 2013 Mar; 31(7):868-75. PubMed ID: 23341533
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of CDH1 gene promoter methylation on expression of E-cadherin and beta-catenin and its clinicopathological significance in colon carcinoma].
    Li C; Dong J; Chen MQ; Li WL; Ren JY; Chen SX; Li QT; Geng JW; Miao YD; Yang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jul; 14(7):538-41. PubMed ID: 21792768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium.
    Nomura T; Tahara T; Shiroeda H; Minato T; Matsue Y; Hayashi R; Matsunaga K; Otsuka T; Nakamura M; Toshikuni N; Shibata T; Arisawa T
    BMC Gastroenterol; 2013 Jan; 13():1. PubMed ID: 23280118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methylation status of the fragile histidine triad and E-cadherin genes in plasma of cervical cancer patients.
    Ren CC; Miao XH; Yang B; Zhao L; Sun R; Song WQ
    Int J Gynecol Cancer; 2006; 16(5):1862-7. PubMed ID: 17009983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Promoter methylation and expression of CDH1 and susceptibility and prognosis of eyelid squamous cell carcinoma.
    Wang YQ; Yuan Y; Jiang S; Jiang H
    Tumour Biol; 2016 Jul; 37(7):9521-6. PubMed ID: 26790440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retrospective protein expression and epigenetic inactivation studies of CDH1 in patients affected by low-grade glioma.
    D'Urso PI; D'Urso OF; Storelli C; Catapano G; Gianfreda CD; Montinaro A; Muscella A; Marsigliante S
    J Neurooncol; 2011 Aug; 104(1):113-8. PubMed ID: 21127944
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
    Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D
    Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer.
    Graziano F; Arduini F; Ruzzo A; Bearzi I; Humar B; More H; Silva R; Muretto P; Guilford P; Testa E; Mari D; Magnani M; Cascinu S
    Clin Cancer Res; 2004 Apr; 10(8):2784-9. PubMed ID: 15102685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review.
    de Ruijter TC; van der Heide F; Smits KM; Aarts MJ; van Engeland M; Heijnen VCG
    Breast Cancer Res; 2020 Jan; 22(1):13. PubMed ID: 32005275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma.
    Kontic M; Stojsic J; Jovanovic D; Bunjevacki V; Ognjanovic S; Kuriger J; Puumala S; Nelson HH
    Clin Lung Cancer; 2012 Jul; 13(4):297-303. PubMed ID: 22169480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.